We narrowed to 55,775 results for: ran

1. pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (AAV1)

   Viral Prep

   #125712-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (#125712). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE plasmid DNA. CaMKIIa-driven expression of the optimized mosquito OPN3 rhodopsin in-frame with mScarlet. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ofer Yizhar

   Article

   Mahn et al Neuron. 2021 May 10. pii: S0896-6273(21)

   Promoter

   short version of αCamKinase II promoter (0.4kb)

   Tags

   mScarlet

   Available Since

   June 26, 2024

   Availability

   Academic Institutions and Nonprofits only

2. pAAV.hSyn.FLEX.iGluSnFR3.v857.PDGFR.codonopt (AAV1)

   Viral Prep

   #175180-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV.hSyn.FLEX.iGluSnFR3.v857.PDGFR.codonopt (#175180). In addition to the viral particles, you will also receive purified pAAV.hSyn.FLEX.iGluSnFR3.v857.PDGFR.codonopt plasmid DNA. Synapsin-driven, Cre-dependent, iGluSnFR3 glutamate sensor. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Kaspar Podgorski

   Article

   Aggarwal et al Nat Methods. 2023 May 4. doi: 10.1038/s4

   Promoter

   Syn

   Available Since

   July 1, 2022

   Availability

   Academic Institutions and Nonprofits only

3. pAAV.CAG.FLEX.iGluSnFR3.v857.PDGFR (AAV2)

   Viral Prep

   #196219-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV.CAG.FLEX.iGluSnFR3.v857.PDGFR (#196219). In addition to the viral particles, you will also receive purified pAAV.CAG.FLEX.iGluSnFR3.v857.PDGFR plasmid DNA. CAG-driven, Cre-dependent third generation glutamate sensor iGluSnFR3, variant 857. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Kaspar Podgorski

   Article

   Aggarwal et al Nat Methods. 2023 May 4. doi: 10.1038/s4

   Available Since

   Aug. 6, 2025

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-S5E2-GCaMP6f (AAV1)

   Viral Prep

   #135632-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-GCaMP6f (#135632). In addition to the viral particles, you will also receive purified pAAV-S5E2-GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Available Since

   Nov. 11, 2020

   Availability

   Academic Institutions and Nonprofits only

5. TUNEYALI-TF Library

   Pooled Library

   #217744

   Purpose

   Regulating transcription factors in Yarrowia lipolytica

   Depositor

   Irina Borodina

   Expression

   Yeast

   Available Since

   May 20, 2025

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-S5E2-C1V1-eYFP (AAV1)

   Viral Prep

   #135633-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   EYFP

   Available Since

   Aug. 27, 2021

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-S5E2-ChR2-mCherry (AAV9)

   Viral Prep

   #135634-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   mCherry

   Available Since

   Sept. 15, 2021

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-S5E2-Gq-P2A-dTomato (AAV9)

   Viral Prep

   #135635-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-Gq-P2A-dTomato (#135635). In addition to the viral particles, you will also receive purified pAAV-S5E2-Gq-P2A-dTomato plasmid DNA. Expression of Gq-DREADD and dTomato (physically separate) under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato (physically separate, not a fusion protein)

   Available Since

   Aug. 27, 2021

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-S5E2-dTom-nlsdTom (AAV1)

   Viral Prep

   #135630-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (AAV Retrograde)

    Viral Prep

    #125712-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE (#125712). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa(0.4)-eOPN3-mScarlet-WPRE plasmid DNA. CaMKIIa-driven expression of the optimized mosquito OPN3 rhodopsin in-frame with mScarlet. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Neuron. 2021 May 10. pii: S0896-6273(21)

    Promoter

    short version of αCamKinase II promoter (0.4kb)

    Available Since

    Jan. 8, 2025

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-S5E2-dTom-nlsdTom (AAV9)

    Viral Prep

    #135630-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    dTomato

    Available Since

    Nov. 29, 2021

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-S5E2-ChR2-mCherry (AAV1)

    Viral Prep

    #135634-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    mCherry

    Available Since

    Nov. 29, 2021

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-S5E2-C1V1-eYFP (AAV9)

    Viral Prep

    #135633-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    EYFP

    Available Since

    Aug. 27, 2021

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-S5E2-Gq-P2A-dTomato (AAV1)

    Viral Prep

    #135635-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-S5E2-Gq-P2A-dTomato (#135635). In addition to the viral particles, you will also receive purified pAAV-S5E2-Gq-P2A-dTomato plasmid DNA. Expression of Gq-DREADD and dTomato (physically separate) under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    dTomato (physically separate, not a fusion protein)

    Available Since

    Nov. 29, 2021

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-S5E6-dTom-nlsdTom (AAV1)

    Viral Prep

    #135641-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-S5E6-dTom-nlsdTom (#135641). In addition to the viral particles, you will also receive purified pAAV-S5E6-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato in VIP cortical interneurons under the control of the E6 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    dTomato

    Available Since

    Feb. 6, 2025

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-S5E2-C1V1-eYFP (AAV5)

    Viral Prep

    #135633-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    EYFP

    Available Since

    Oct. 8, 2020

    Availability

    Academic Institutions and Nonprofits only

17. ScEnSor Kit

    Plasmid Kit

    #1000000215

    Purpose

    This three-step (Build - Transform - Assess) Saccharomyces cerevisiae kit is comprised of two modules (Engineering and Biosensor) that can be used independently or in combination.

    Depositor

    Lisbeth Olsson

    Available Since

    May 8, 2023

    Availability

    Academic Institutions and Nonprofits only

18. MultiGreen

    Plasmid Kit

    #1000000250

    Purpose

    The MultiGreen kit enables users to assemble GreenGate-compatible multigene plant transformation vectors.

    Depositor

    Wayne Parrott

    Available Since

    Dec. 16, 2024

    Availability

    Academic Institutions and Nonprofits only

19. Tol2 Gateway compatible toolbox for the study of the nervous system and neurodegenerative disease

    Plasmid Kit

    #1000000087

    Purpose

    Tol2 Zebrafish toolkit: 4 promoters, 6 fluorophores, MultiSite Gateway (Invitrogen) compatible and cloning sites. Production transgenic zebrafish for neurodegenerative disorders

    Depositor

    Nicholas Cole

    Available Since

    Oct. 13, 2016

    Availability

    Academic Institutions and Nonprofits only

20. cpFRET

    Plasmid Kit

    #1000000021

    Purpose

    circular permutation-based fluorescence resonance energy transfer (cpFRET) biosensor toolkit: generate and optimize genetically encoded, unimolecular FRET sensors for ratiometric measurements

    Depositor

    Olivier Pertz

    Available Since

    July 5, 2013

    Availability

    Academic Institutions and Nonprofits only